Statin Clinical Trials

5 recruiting

Statin Trials at a Glance

22 actively recruiting trials for statin are listed on ClinicalTrialsFinder across 6 cities in 17 countries. The largest study group is Not Applicable with 6 trials, with the heaviest enrollment activity in Barcelona, Seoul, and Dallas. Lead sponsors running statin studies include Insel Gruppe AG, University Hospital Bern, National Cancer Institute (NCI), and ITM Solucin GmbH.

Browse statin trials by phase

Treatments under study

About Statin Clinical Trials

Looking for clinical trials for Statin? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Statin trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Statin clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 22 trials

Recruiting
Phase 2

A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy

Spinal Muscular AtrophySMASpinal Muscular Atrophy Type 3+3 more
Scholar Rock, Inc.52 enrolled25 locationsNCT07047144
Recruiting
Phase 3

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET

Somatostatin Receptor Positive (SSTR+)Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
Novartis Pharmaceuticals240 enrolled65 locationsNCT06784752
Recruiting
Phase 1

Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors

Solid TumorLymphomaGIST+5 more
ITM Solucin GmbH20 enrolled5 locationsNCT06441331
Recruiting
Phase 1

[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers

Kidney CancersHead and Neck TumorsSmall Cell Lung Cancers+3 more
National Cancer Institute (NCI)120 enrolled1 locationNCT06479811
Recruiting
Phase 1

Safety and Efficacy of LOw DOse COlchicine in Patients With STatin INTolerance: the LODOCO STINT Pilot Study

Statin Adverse Reaction
Virginia Commonwealth University30 enrolled1 locationNCT06874192
Recruiting
Phase 1

Using Novel Imaging to More Safely Treat Neuroendocrine Tumors

Neuroendocrine TumorsSomatostatin Receptor-positive Neuroendocrine Tumor
University of Wisconsin, Madison10 enrolled1 locationNCT06122610
Recruiting
Phase 1Phase 2

Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendocrine Tumor and Pheochromocytoma/Paraganglioma Previously Treated With Systemic Targeted Radioligand Therapy

PheochromocytomaGastrointestinal Neuroendocrine TumorsSomatostatin Receptor Positive+1 more
National Cancer Institute (NCI)66 enrolled1 locationNCT06427798
Recruiting
Not Applicable

Ursodeoxycholic Acid Attenuates Statin-Induced Impaired Glucose Tolerance

HyperlipidemiaGlucose IntoleranceStatin Therapy+1 more
First Affiliated Hospital Xi'an Jiaotong University128 enrolled2 locationsNCT06684106
Recruiting

"The Effect of The Combination Therapy of Statin and SGLT2i in The Treatment of Ischemic Heart Disease"

2 Drugs Are Statin and SGLT2i
Fayoum University90 enrolled1 locationNCT06520891
Recruiting
Not Applicable

Changes in Plaque Characteristics After Short-term Statin Therapy as Assessed With Coronary CT

Cardiovascular DiseasesHeart DiseasesCoronary Artery Disease+7 more
Prof. Maurovich-Horvat Pál140 enrolled1 locationNCT06603363
Recruiting
Phase 4

Low Dose Rosuvastatin Plus Ezetimibe Versus High-dose Rosuvastatin in AMI

Myocardial InfarctionStatin Adverse ReactionHMG-CoA Reductase Inhibitor Toxicity
Kiyuk Chang, MD,PhD3,548 enrolled7 locationsNCT04499859
Recruiting
Phase 4

Comparison of Pitavastatin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus

DiabetesASCVDStatin
Korea University Anam Hospital2,000 enrolled1 locationNCT06767774
Recruiting

Efficacy of Probucol Combined with Statins Treatment for Ischemic Stroke

Ischemic StrokeLipid DisorderStatin+1 more
Xuanwu Hospital, Beijing200 enrolled1 locationNCT06604117
Recruiting
Phase 4

DESIFOR-EXPAND (MHIF)

StatinStatin TherapyStatin Adverse Reaction
Minneapolis Heart Institute Foundation100 enrolled1 locationNCT06804980
Recruiting
Not Applicable

Role of Coronary CTA on Lipid Management and Risk Factors Control in an Asymptomatic Chinese Population

Cardiovascular Risk FactorsAdherence, MedicationPrimary Prevention+1 more
Zhang longjiang,MD3,400 enrolled1 locationNCT05725096
Recruiting
Phase 4

Statin Combined with Amlodipine Treats Primary Aldosteronism

HypertensionPrimary AldosteronismStatin+1 more
Third Military Medical University180 enrolled1 locationNCT06523465
Recruiting

Hepatic Safety of Statin Use in Neurology Inpatients

Statin Adverse Reaction
Shanghai Yueyang Integrated Medicine Hospital2,000 enrolled1 locationNCT06592196
Recruiting
Not Applicable

Treatment of Intrabony Defects With Simvastatin and Antimicrobial Photodynamic Therapy

Periodontal DiseasesPhotodynamic TherapySimvastatin
Kafrelsheikh University20 enrolled1 locationNCT05031923
Recruiting
Not Applicable

STREAM Trial - Subclinical Atherosclerosis

Statin Treatment for Primary Prevention
Insel Gruppe AG, University Hospital Bern500 enrolled1 locationNCT05482399
Recruiting
Not Applicable

STREAM Trial - Biomarker

Statin Treatment for Primary Prevention
Insel Gruppe AG, University Hospital Bern500 enrolled1 locationNCT05482386